HEADER TRANSFERASE/TRANSFERASE INHIBITOR 26-AUG-16 5T3Q TITLE CRYSTAL STRUCTURE OF THE C-MET KINASE DOMAIN IN COMPLEX WITH A TITLE 2 PYRAZOLONE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 6 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: KINASE DOMAIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS PHOSPHOTRANSFERASE, CANCER, INHIBITOR, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.F.BELLON,D.A.WHITTINGTON,A.M.LONG REVDAT 3 03-APR-24 5T3Q 1 REMARK REVDAT 2 06-MAR-24 5T3Q 1 REMARK REVDAT 1 21-SEP-16 5T3Q 0 JRNL AUTH A.A.BOEZIO,E.A.PETERSON,J.-C.HARMANGE JRNL TITL DISCOVERY OF AMG337: USING STRUCTURE GUIDED SCAFFOLD JRNL TITL 2 HYDRIDIZATION TO OPTIMIZE PHYSICOCHEMICAL PROPERTIES AND JRNL TITL 3 TARGET COVERAGE OF A MET KINASE INHIBITOR JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.5 REMARK 3 NUMBER OF REFLECTIONS : 22650 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1215 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2213 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 218 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.86000 REMARK 3 B22 (A**2) : -0.66000 REMARK 3 B33 (A**2) : -0.20000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.180 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.171 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.122 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.470 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES: REFINED INDIVIDUALLY REMARK 4 REMARK 4 5T3Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-AUG-16. REMARK 100 THE DEPOSITION ID IS D_1000223611. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-DEC-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : VARIMAX HR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23885 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 61.5 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : 0.30800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PROPRIETARY CMET STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 6000, 1.0 M LITHIUM CHLORIDE, REMARK 280 0.1 M SODIUM CITRATE (PH 5.0), VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.56950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.56950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 35.81350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 41.13600 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 35.81350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 41.13600 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 63.56950 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 35.81350 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 41.13600 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 63.56950 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 35.81350 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 41.13600 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1700 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 1048 REMARK 465 ASN A 1049 REMARK 465 ARG A 1086 REMARK 465 GLY A 1087 REMARK 465 PHE A 1223 REMARK 465 GLY A 1224 REMARK 465 LEU A 1225 REMARK 465 ALA A 1226 REMARK 465 ARG A 1227 REMARK 465 ASP A 1228 REMARK 465 MET A 1229 REMARK 465 TYR A 1230 REMARK 465 ASP A 1231 REMARK 465 LYS A 1232 REMARK 465 GLU A 1233 REMARK 465 TYR A 1234 REMARK 465 TYR A 1235 REMARK 465 SER A 1236 REMARK 465 VAL A 1237 REMARK 465 HIS A 1238 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 465 ALA A 1243 REMARK 465 LYS A 1244 REMARK 465 HIS A 1352 REMARK 465 HIS A 1353 REMARK 465 HIS A 1354 REMARK 465 HIS A 1355 REMARK 465 HIS A 1356 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A1203 -23.62 82.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1717 DISTANCE = 6.14 ANGSTROMS REMARK 525 HOH A1718 DISTANCE = 6.88 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 75H A 1401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3U6I RELATED DB: PDB DBREF 5T3Q A 1048 1350 UNP P08581 MET_HUMAN 1066 1368 SEQADV 5T3Q HIS A 1351 UNP P08581 EXPRESSION TAG SEQADV 5T3Q HIS A 1352 UNP P08581 EXPRESSION TAG SEQADV 5T3Q HIS A 1353 UNP P08581 EXPRESSION TAG SEQADV 5T3Q HIS A 1354 UNP P08581 EXPRESSION TAG SEQADV 5T3Q HIS A 1355 UNP P08581 EXPRESSION TAG SEQADV 5T3Q HIS A 1356 UNP P08581 EXPRESSION TAG SEQRES 1 A 309 GLN ASN THR VAL HIS ILE ASP LEU SER ALA LEU ASN PRO SEQRES 2 A 309 GLU LEU VAL GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SEQRES 3 A 309 SER SER LEU ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG SEQRES 4 A 309 GLY HIS PHE GLY CYS VAL TYR HIS GLY THR LEU LEU ASP SEQRES 5 A 309 ASN ASP GLY LYS LYS ILE HIS CYS ALA VAL LYS SER LEU SEQRES 6 A 309 ASN ARG ILE THR ASP ILE GLY GLU VAL SER GLN PHE LEU SEQRES 7 A 309 THR GLU GLY ILE ILE MET LYS ASP PHE SER HIS PRO ASN SEQRES 8 A 309 VAL LEU SER LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SEQRES 9 A 309 SER PRO LEU VAL VAL LEU PRO TYR MET LYS HIS GLY ASP SEQRES 10 A 309 LEU ARG ASN PHE ILE ARG ASN GLU THR HIS ASN PRO THR SEQRES 11 A 309 VAL LYS ASP LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS SEQRES 12 A 309 GLY MET LYS TYR LEU ALA SER LYS LYS PHE VAL HIS ARG SEQRES 13 A 309 ASP LEU ALA ALA ARG ASN CYS MET LEU ASP GLU LYS PHE SEQRES 14 A 309 THR VAL LYS VAL ALA ASP PHE GLY LEU ALA ARG ASP MET SEQRES 15 A 309 TYR ASP LYS GLU TYR TYR SER VAL HIS ASN LYS THR GLY SEQRES 16 A 309 ALA LYS LEU PRO VAL LYS TRP MET ALA LEU GLU SER LEU SEQRES 17 A 309 GLN THR GLN LYS PHE THR THR LYS SER ASP VAL TRP SER SEQRES 18 A 309 PHE GLY VAL LEU LEU TRP GLU LEU MET THR ARG GLY ALA SEQRES 19 A 309 PRO PRO TYR PRO ASP VAL ASN THR PHE ASP ILE THR VAL SEQRES 20 A 309 TYR LEU LEU GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR SEQRES 21 A 309 CYS PRO ASP PRO LEU TYR GLU VAL MET LEU LYS CYS TRP SEQRES 22 A 309 HIS PRO LYS ALA GLU MET ARG PRO SER PHE SER GLU LEU SEQRES 23 A 309 VAL SER ARG ILE SER ALA ILE PHE SER THR PHE ILE GLY SEQRES 24 A 309 GLU HIS TYR VAL HIS HIS HIS HIS HIS HIS HET 75H A1401 41 HETNAM 75H N-{3-FLUORO-4-[(7-METHOXYQUINOLIN-4-YL)OXY]PHENYL}-1- HETNAM 2 75H (2-HYDROXY-2-METHYLPROPYL)-5-METHYL-3-OXO-2-PHENYL-2, HETNAM 3 75H 3-DIHYDRO-1H-PYRAZOLE-4-CARBOXAMIDE FORMUL 2 75H C31 H29 F N4 O5 FORMUL 3 HOH *218(H2 O) HELIX 1 AA1 ASP A 1054 LEU A 1058 5 5 HELIX 2 AA2 ASN A 1059 GLN A 1067 1 9 HELIX 3 AA3 HIS A 1068 VAL A 1070 5 3 HELIX 4 AA4 ASP A 1117 PHE A 1134 1 18 HELIX 5 AA5 ASP A 1164 ASN A 1171 1 8 HELIX 6 AA6 THR A 1177 LYS A 1198 1 22 HELIX 7 AA7 ALA A 1206 ARG A 1208 5 3 HELIX 8 AA8 PRO A 1246 MET A 1250 5 5 HELIX 9 AA9 ALA A 1251 GLN A 1258 1 8 HELIX 10 AB1 THR A 1261 THR A 1278 1 18 HELIX 11 AB2 ASN A 1288 PHE A 1290 5 3 HELIX 12 AB3 ASP A 1291 GLN A 1298 1 8 HELIX 13 AB4 PRO A 1309 TRP A 1320 1 12 HELIX 14 AB5 LYS A 1323 ARG A 1327 5 5 HELIX 15 AB6 SER A 1329 THR A 1343 1 15 SHEET 1 AA1 5 LEU A1076 VAL A1083 0 SHEET 2 AA1 5 CYS A1091 LEU A1098 -1 O HIS A1094 N HIS A1079 SHEET 3 AA1 5 LYS A1104 SER A1111 -1 O SER A1111 N CYS A1091 SHEET 4 AA1 5 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 5 AA1 5 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156 SHEET 1 AA2 2 CYS A1210 LEU A1212 0 SHEET 2 AA2 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SITE 1 AC1 15 ILE A1084 VAL A1092 ALA A1108 PHE A1124 SITE 2 AC1 15 GLU A1127 MET A1131 LEU A1140 LEU A1157 SITE 3 AC1 15 PRO A1158 TYR A1159 MET A1160 MET A1211 SITE 4 AC1 15 ALA A1221 ASP A1222 HOH A1613 CRYST1 71.627 82.272 127.139 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013961 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012155 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007865 0.00000